Lev D Bubis
Overview
Explore the profile of Lev D Bubis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bubis L, Behman R, Roke R, Serrano P, Khalil J, Coburn N, et al.
HPB (Oxford)
. 2021 Jun;
24(1):72-78.
PMID: 34176743
Background: Post-operative pancreatic fistula (POPF) is the most significant cause of morbidity following distal pancreatectomy. Hemopatch™ is a thin, bovine collagen-based hemostatic sealant. We hypothesized that application of Hemopatch™ to...
2.
Bubis L, Coburn N, Sutradhar R, Gupta V, Jeong Y, Davis L, et al.
J Surg Res
. 2020 Dec;
259:86-96.
PMID: 33279848
Background: Rectal cancer patients undergoing preoperative radiotherapy experience a significant symptom burden. However, it is unknown whether symptoms during radiotherapy may portend adverse postoperative outcomes and healthcare utilization. Methods: A...
3.
Mavros M, Davis L, Hallet J, Tung S, Mahar A, Bubis L, et al.
Pancreas
. 2020 Aug;
49(8):1083-1089.
PMID: 32769858
Objectives: Pancreatic adenocarcinoma (PAC) is a debilitating disease. We sought to analyze symptom burden and trajectories after diagnosis of PAC and identify predictors of severe symptoms for nonresected patients. Methods:...
4.
Bubis L, Delibasic V, Davis L, Jeong Y, Chan K, Kosyachkova E, et al.
Support Care Cancer
. 2020 May;
29(1):515-524.
PMID: 32415385
Background: Patients with metastatic gastric cancer have poor survival outcomes and may experience high symptom burden. We evaluated symptom trajectory and risk factors for increased symptom severity among metastatic gastric...
5.
Allen-Ayodabo C, Eskander A, Davis L, Zhao H, Mahar A, Karam I, et al.
Oral Oncol
. 2019 Oct;
99:104434.
PMID: 31630058
Purpose: Head and neck cancer (HNC) and its treatment affects quality of life, with significant symptom burden. The main objectives of this study were to examine symptom trajectories of HNC...
6.
Bubis L, Davis L, Coburn N, Mahar A
J Pain Symptom Manage
. 2019 Oct;
59(1):e3-e4.
PMID: 31610270
No abstract available.
7.
Vela N, Bubis L, Davis L, Mahar A, Kennedy E, Coburn N
Dis Colon Rectum
. 2019 Oct;
62(12):1439-1447.
PMID: 31567922
Background: Open and laparoscopic resections for colon cancer have equivalent perioperative morbidity and mortality. However, there are little data concerning patient-reported outcomes in the early postdischarge period. Objective: We examined...
8.
Vela N, Davis L, Cheng S, Hammad A, Liu Y, Kagedan D, et al.
Ann Surg Oncol
. 2019 Sep;
26(13):4193-4203.
PMID: 31535303
Background: Population-based survival and costs of pancreas adenocarcinoma patients receiving adjuvant chemoradiation and chemotherapy following pancreaticoduodenectomy are poorly understood. Methods: This retrospective cohort study used linked administrative and pathological datasets...
9.
Tung S, Davis L, Hallet J, Mavros M, Mahar A, Bubis L, et al.
JAMA Surg
. 2019 Sep;
154(11):e193348.
PMID: 31483457
Importance: Postoperative morbidity associated with pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PA) remains as high as 70%. However, to our knowledge, few studies have examined quality of life in this patient...
10.
Bubis L, Davis L, Canaj H, Gupta V, Jeong Y, Barbera L, et al.
J Pain Symptom Manage
. 2019 Aug;
59(1):58-66.e4.
PMID: 31430522
Context: Understanding the magnitude and risk factors for symptom burden of patients with cancer at the end of life is critical to guiding effective patient- and system-level interventions. Objectives: We...